agence france-presse
click here to return to agence france-presse main menu
DonateNow
SAfrica-health-AIDS-business: AIDS slashes company profits in South Africa: survey

Agence France-Presse - December 10, 2003


JOHANNESBURG, Dec 10 (AFP) - South Africa's rocketing AIDS rates have slashed profits in at least a third of companies surveyed in the largest such domestic study, published on Wednesday.

"HIV/AIDS is undoubtedly a bottom-line issue for business, as it impacts on production costs and consumer markets," Leighton McDonald, spokesman for the South African Business Coalition on HIV and AIDS (SABCOHA), told reporters here.

"Approximately a third of the companies surveyed reported that HIV/AIDS has already had an negative impact on profits, while more than half expect an adverse impact on profitability in five years' time," he said.

SABCOHA announced the results of a survey examining the impact of AIDS on 1,006 companies in South Africa.

The UN agency UNAIDS has estimated that South Africa had 5.3 million infected adults at the end of 2002 -- the highest number of any country in the world.

The Johannesburg-based Bureau for Economic Research interviewed business leaders in October and November this year, with about a third reporting reduced labour productivity or increased absenteeism as a result of AIDS.

Taking all factors into consideration, nine percent of the companies said HIV/AIDS had already had a significant adverse impact on the business overall, while 43 percent envisaged a significant negative impact within five years' time.

About 30 percent of businesses reported higher labour turnover, while a similar amount complained they had lost experience and skills. Just over 20 percent had incurred recruitment and training costs due to the AIDS epidemic.

"Given that only eight percent of all the companies surveyed expect to be able to pass some of these HIV/AIDS related costs on to customers by increasing their selling prices, it is not surprising that so many reported that HIV/AIDS is having an adverse impact on profits," McDonald said.

However, it seemed that the disease had a smaller impact on the demand side than the production side, with less than 10 percent noting a negative impact on their sales.

McDonald said a matter of concern was the low level of response to the endemic, especially in companies with fewer than 100 employees.

"Only a quarter of all the firms surveyed have implemented a formal HIV/AIDS policy, while less than a fifth have a voluntary counselling and testing programme, or provide care, treatment and support to infected workers."

Some of South Africa's largest companies, including mining giants Anglo American and Goldfields, as well as South African Breweries, have launched AIDS programmes to provide drugs for infected employees, pre-empting an expected surge in deaths.

The United Nations warned in November that South Africa -- where almost 1,000 citizens die of AIDS every day -- would soon enter a "death phase" where many HIV-positive people would contract full-blown AIDS.

031210
AF031269


©AFP 2003. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission. obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. -   http://www.afp.com/

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

©1990, 2003 - AEGiS. AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.